Document is current
Any future updates will be listed below
-
Authors
Yang, Jiqiao
He, Tao
Wu, Yunhao
Fu, Zhoukai
Lv, Qing
Lu, Shan
Wang, Xiaodong
Li, Hongjiang
Wang, Jing
Chen, Jie https://orcid.org/0000-0002-7712-5982
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr2000039814 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
Nanoparticle-assisted axillary staging: an alternative approach after neoadjuvant chemotherapy in patients with pretreatment node-positive breast cancers
https://doi.org/10.1007/s10549-022-06539-x
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32071284, 81902686)
the Program of the Science and Technology Bureau of Sichuan (2019YFS0338)
- License Information
-
More Information
Article History
Received: 17 November 2021
Accepted: 29 January 2022
First Online: 7 February 2022
Declarations
:
: The authors declare no conflict of interest.
: This study was approval by the Chinese Ethics Committee of Registering Clinical Trials (ChiECRCT20200341).
: Written informed consent was obtained from all patients.
